B
BSX icon

Birchbrook’s Boston Scientific BSX Stock Holding History

Birchbrook’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.7K Sell
110
-100
-48% -$5.43K ﹤0.01% 238
2026
Q1 		$13.2K Hold
210
– – 0.01% 184
2025
Q4 		$20K Buy
210
+50
+31% +$4.9K 0.01% 175
2025
Q3 		$15.6K Hold
160
– – 0.01% 173
2025
Q2 		$17.2K Buy
160
+100
+167% +$10.1K 0.01% 169
2025
Q1 		$6.05K Hold
60
– – ﹤0.01% 204
2024
Q4 		$5.36K Hold
60
– – ﹤0.01% 227
2024
Q3 		$5.03K Hold
60
– – ﹤0.01% 214
2024
Q2 		$4.62K Hold
60
– – ﹤0.01% 217
2024
Q1 		$4.11K Hold
60
– – ﹤0.01% 227
2023
Q4 		$3.47K Buy
+60
New +$3.2K ﹤0.01% 254

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Birchbrook's BSX Position: Q2 2026 in Review

Birchbrook reduced its Boston Scientific (BSX) stake by 48% in Q2 2026, selling an estimated $5.43K and leaving 110 shares worth $4.7K. The position accounts for ﹤0.01% of the portfolio, ranked #238.

Birchbrook first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $20K in Q4 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Birchbrook held 110 shares of Boston Scientific worth $4.7K as of Q2 2026.
  • Birchbrook sold 100 Boston Scientific shares in Q2 2026, an estimated $5.43K.
  • Boston Scientific made up ﹤0.01% of Birchbrook's portfolio in Q2 2026, its #238 holding.
  • Birchbrook first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Birchbrook's Boston Scientific position peaked at $20K in Q4 2025.
  • 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Birchbrook's 13F filing for Q2 2026, filed 9 Jul 2026.